|
Vitalzym SEB is formulated with your cardiovascular well-being in mind. The SEBkinase blend contains "heart healthy" enzymes that may cleanse the blood of excess fibrin and reduce vascular inflammation. It also contains powerful antioxidants, such as CoQ10 that has been shown to have significant impact on heart function. Introduced in 2002, the original Vitalzym has become the leading systemic enzyme formulation recommended for pain, inflammation, and scar tissue. Countless sufferers of chronic conditions, such as arthritis, fibromyalgia, systemic inflammation, fibroids, and many more have found relief with the regular use of Vitalzym. A common benefit of Vitalzym has been its ability to cleanse the blood and reduce vascular inflammation. World Nutrition and Specialty Enzymes have taken the cardiovascular benefits of Vitalzym and harnessed them with nattokinase and other "heart healthy" nutrients to create an enzyme formulation specifically for cardiovascular wellness.
Reduce Fibrin in the Blood
The fibrinolytic enzymes in VitalzymSEB have been shown to have the ability to digest excess fibrin (protein buildup) in the blood, allowing for improved blood viscosity. Stacked red blood cells (or Rouleau effect) often reflect poor protein digestion. Symptoms can include fatigue, stress on the heart, and poor circulation. The ingredients in VitalzymSEB have been shown, using darkfield microscopy, to significantly reduce stacked red blood cells. Below, you can see the effect of proteolytic enzymes reducing stacked red blood cells.
Reduce Vascular Inflammation
Recent studies have shown the correlation between elevated vascular inflammation and heart disease. The enzymes in VitalzymSEB have been shown to reduce the levels of C-Reactive Proteins (inflammation marker).
Frequently Asked Questions
Ingredients for Vitalzym SEB:
Proprietary Blend contains SEBkinase (blend of Nattokinase and Serratiopeptidase), Bromelain, Papain, Lipase, Protease, Rutin, Amla, CoQ10, and Magnesium
Nattokinase
Nattokinase is a profibrinolytic enzyme extracted and purified from the essence of natto, a fermented soybean food used by the Japanese for thousands of years as a traditional food medicine. Nattokinase was first identified in 1980 by Dr. Hiroyuki Sumi, M.D., Ph.D., who was researching thrombolytic enzymes with the hope of finding a natural agent that could successfully dissolve thrombus associated with cardiac and cerebral infarction (blood clots associated with heart attacks and stroke). After testing more than 200 natural foods as potential thrombolytic agents, Sumi found that natto possessed a substance with "a potency matched by no other enzyme." Dr. Sumi named the newly discovered enzyme nattokinase. By dissolving fibrin more completely than any other substance tested by Dr. Sumi, nattokinase is particularly effective in helping the body fight blood clots. Its thrombolytic activity is enhanced by the enzyme’s ability to boost the body’s production of both plasmin and other clot-dissolving agents, including endogenous urokinase. Many healthcare professionals believe nattokinase to be superior to conventional clot-dissolving drugs. Nattokinase is also characterized by its unmatched length of activity, which ranges from 8- 12 hours after it is orally consumed. This is in stark contrast to the antithrombin drugs that wear off within minutes following IV treatment. This activity is achieved in two ways:
nattokinase prevents coagulation of blood, and it dissolves existing thrombus. Both the efficacy and the prolonged action of nattokinase can be determined by measuring levels of EFA (euglobulin fibrinolytic activity) and FDP (fibrin degradation products), which both become elevated as fibrin is being dissolved. By measuring EFA & FDP levels, activity of nattokinase has been determined to last from 8 to 12 hours. An additional parameter for confirming the action of nattokinase following oral administration is a rise in blood levels of TPA antigen (tissue plasminogen activator), which indicates a release of TPA from the endothelial cells and/or the liver.
Nattokinase has been the subject of 17 studies, including two small human trials.
Dr. Sumi and his colleagues induced blood clots in male dogs, then orally administered either four capsules of nattokinase (250 mg per capsule) or four placebo capsules to each dog. Angiograms (X-rays of blood vessels) revealed that the dogs who received nattokinase regained normal blood circulation (free of the clot) within five hours of treatment. Blood clots in the dogs who received only placebo showed no sign of dissolving in the 18 hours following treatment.
Researchers from Biotechnology Research Laboratories and JCR Pharmaceuticals Co. of Kobe, Japan, tested nattokinase's ability to dissolve a thrombus in the carotid arteries of rats. Animals treated with nattokinase regained 62 percent of blood flow, whereas those treated with plasmin regained just 15.8 percent of blood flow.1 Researchers from JCR Pharmaceuticals, Oklahoma State University, and Miyazaki Medical College tested nattokinase on 12 healthy Japanese volunteers (6 men and 6 women, between the ages of 21 and 55). They gave the volunteers 200 grams of natto (the food) before breakfast, then tracked fibrinolytic activity through a
series of blood plasma tests. The tests indicated that the natto generated a heightened ability to dissolve blood clots: On average, the volunteers' ELT (a measure of how long it takes to dissolve a blood clot) dropped by 48 percent within two hours of treatment, and volunteers retained an enhanced ability to dissolve blood clots for 2 to 8 hours. As a control, researchers later fed the same 30 amount of boiled soybeans to the same volunteers and tracked their fibrinolytic activity. The tests showed no significant change.
The Benefits of Nattokinase on Blood Pressure
Traditionaly in Japan, Natto has been consumed not only for cardiovascular support, but also to lower blood pressure. In recent years, this traditional belief has been confirmed by several clinical trials. In 1995, researchers from Miyazaki Medical College and Kurashiki University of Science and Arts in Japan studied the effects of nattokinase on blood pressure in both animal and human subjects (see below). In addition, the researchers confirmed the presence of inhibitors of angiotensin converting enzyme (ACE), which converts angiotensin I to its active form angiotensin II within the test extract, which consisted of 80% ethanol extract of lyophilized viscous materials of natto. ACE causes blood vessels to narrow and blood pressure to rise - by inhibiting ACE, nattokinase has a lowering effect on blood pressure.
Animal Study
After a single intraperitoneal administration of 400-450 grams of the test extract (equivalent to 25 mg of natto food) into male Wister rats, systolic blood pressure (SBP) significantly decreased from 166 + mmHg to 145 + 24 mmHg in just two hours (p<0.05), and decreased further to 144 + 27 mmHg in 3 hours (p<0.05). On average, this data represents a 12.7 percent drop in SBP within two hours.
Human Study
The same natto extract was then tested on human volunteers with high blood pressure.
Blood pressure levels were measured after 30 grams of lyophilized extract (equivalent to 200 grams of natto food) was administered orally for 4 consecutive days. In 4 out of 5 volunteers, the systolic blood pressure (SBP) decreased on average from 173.8 + 20.5 mmHg to 154.8 + 12.6 mmHg. Diastolic blood pressure (DBP) decreased on average from 101.0 + 11.4 mmHg to 91.2 + 6.6 mmHg. On average, this data represents a 10.9 percent drop in SBP and a 9.7 percent drop in DBP.
Conclusion
The traditional Japanese food Natto has been used safely for over 1000 years. The potent fibrinolytic enzyme nattokinase appears to be safe based upon the long-term traditional use of this food. Nattokinase has many benefits including convenience of oral administration, confirmed efficacy, prolonged effects, cost effectiveness, and can be used preventatively. It is a naturally occurring, food-based dietary supplement that has demonstrated stability in the gastrointestinal tract, as well as to changes in pH and temperature.
Dosage: The recommended dosage is 1 capsule 3 times daily. Dr. Wong strongly recommends not to exceed this dosage without strict supervision from your medical provider. This product is not for hemophiliacs or those on anticoagulants.
Is there any toxicity?
There have been no reports of toxicity from the ingredients, however nattokinase can significantly cleanse, therefore thin, the blood. We suggest staying within the recommended dosage.
What is the difference between Vitalzym and VitalzymSEB? VitalzymSEB was formulated specifically for cardiovascular health. There is a significant amount of nattokinase in the product that may help cleanse arterial plaque. It may also help to reduce fibrin in the circulatory system and help to reduce vascular inflammation. Vitalzym was formulated specifically for pain, inflammation, and systemic fibrosis. Vitalzym's chief fibrinolytic enzyme is serrapeptase. Serrapeptase has the ability to reduce chronic pain, systemic inflammation and systemic fibrosis.
Is VitalzymSEB stronger than Vitalzym?
According to the formulator, it is impossible to compare the two blends in terms of strength as they were formulated for different results. Vitalzym is better for pain, inflammation and systemic fibrosis. It will also help with cleansing the blood and reducing vascular inflammation. VitalzymSEB is better for cleansing excess fibrin in the blood and possibly arterial plaque.
Should I reduce my Vitalzym dosage while taking VitalzymSEB?
There may be a small amount of crossover between Vitalzym and VitalzymSEB. It is recommended to continue with your current Vitalzym dosage if taking for pain and inflammation, however one may be able to slightly reduce their Vitalzym dosage if taking for wellbeing.
The statements made herein have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent disease.
According to the formulator, it is impossible to compare the two blends in terms of strength as they were formulated for different results. Vitalzym is better for pain, inflammation and systemic fibrosis. It will also help with cleansing the blood and reducing vascular inflammation. VitalzymSEB is better for cleansing excess fibrin in the blood and possibly arterial plaque.
Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent disease.
|